SciSparc Ltd. SPRC
5.21
(0.18)
(3.34%)
as of 25 Sep
- Market cap
- $3.1M
- P/E
- 0.0×
Follow SPRC
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '22 | Jun '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | — | — |
P/S ratio |
0.00 | 0.00 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(164.86) | (236.32) | — | — | |
P/B ratio |
146.45 | 112.72 | — | — | |
Price to Tangible BV |
545.31 | 331.60 | — | — | |
EV/Sales |
0.00 | 0.00 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(72.50) | (57.46) | — | — | |
EV/FCF |
(72.65) | (57.58) | — | — | |
Quick Ratio |
0.91 | 0.96 | 1.63 | 0.39 | |
Current Ratio |
1.09 | 1.17 | 1.86 | 0.55 | |
Net Debt/EBITDA |
1.09 | 0.79 | 0.00 | 0.00 | |
Debt/Assets |
0.25% | 0.00% | 0.00% | 47.23% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | (29.96) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(1.81) | 1.12 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | — | |
Intangible Assets out of Total Assets |
0.44 | 0.45 | 0.29 | 0.27 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.00 | 0.00 | — | — | |
Graham Number |
0.00 | 0.00 | — | — | |
Earnings Yield |
(1.70%) | (2.64%) | — | — | |
Free Cash Flow Yield |
(1.37%) | (1.73%) | — | — | |
Revenue per Share |
0.00 | 0.00 | — | — | |
Operating CF per Share |
(21.91) | (11.42) | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | — | |
Free Cash Flow per Share |
(21.91) | (11.42) | 0.00 | 0.00 | |
Cash per Share |
13.90 | 7.50 | 0.00 | 0.00 | |
Shareholders Equity per Share |
24.66 | 23.93 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | — | 0.00 | |
Book value per Share |
24.66 | 23.93 | 0.00 | 0.00 | |
Free Cash Flow |
(5.73) | (3.23) | (2.20) | (1.86) | |
Working Capital |
0.35 | 0.53 | 1.56 | (2.29) | |
Capital Expenditures |
(4.87) | — | 0.00 | — | |
Net Current Asset Value |
0.35 | 0.53 | 1.53 | (2.47) | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | — | — | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Receivables |
0.23 | 0.79 | 1.44 | 0.54 | |
Average Payables |
0.88 | 0.80 | 1.18 | 0.84 | |
Average Assets |
6.58 | 9.12 | 10.20 | 9.78 | |
Average Common Equity |
3.94 | 7.18 | 8.40 | 1.48 |
Columns are period end dates